The medical community in Indonesia is intensifying its focus on Congenital Heart Disease (CHD), a condition that remains a leading cause of neonatal mortality despite advancements in pediatric cardiology. During a comprehensive webinar held on Tuesday, February 14, 2023, Dr. Rizky Adriansyah, MKed, a pediatric specialist and the Chairperson of the Cardiology Coordination Work Unit of the Indonesian Pediatric Society (IDAI), addressed the complexities surrounding CHD. While the exact etiology of congenital heart defects often remains elusive, medical experts have identified a cluster of modifiable risk factors and preventive measures that could significantly reduce the incidence of these conditions if addressed during the critical window of pregnancy.
Congenital Heart Disease refers to structural abnormalities of the heart that develop before birth. These defects can affect the heart walls, valves, or the blood vessels entering or leaving the heart. Dr. Rizky emphasized that while there is no singular definitive cause for every case, the relationship between maternal health during pregnancy and the development of the fetal heart is undeniable. He noted that while many cases appear sporadically, at least three primary risk factors have gained significant attention in recent medical literature as preventable triggers for cardiac malformations.
Navigating the Risks: The Trimester of Vulnerability
The development of the human heart is an intricate process that occurs very early in the first trimester, often before a woman even realizes she is pregnant. It is during this sensitive period that environmental and physiological factors can disrupt the delicate formation of cardiac structures. Dr. Rizky identified the "Big Three" risk factors that are currently at the forefront of clinical discussion: maternal infections, nutritional deficiencies, and the consumption of specific medications.
The Rubella virus, or German measles, stands as one of the most potent threats to fetal heart development. When a pregnant woman contracts Rubella, the virus can cross the placental barrier, leading to Congenital Rubella Syndrome (CRS). This syndrome frequently manifests as a triad of defects, including deafness, cataracts, and significant heart malformations such as Patent Ductus Arteriosus (PDA) or pulmonary artery stenosis.
In addition to viral threats, nutritional status plays a pivotal role. A deficiency in folic acid (Vitamin B9) has long been linked to neural tube defects, but contemporary research increasingly highlights its importance in cardiac organogenesis. Folic acid is essential for DNA synthesis and cell division; a lack thereof can lead to errors in the septation of the heart chambers. Furthermore, the use of certain medications during pregnancy, particularly anticonvulsants used to treat epilepsy or seizures, has been statistically linked to a higher prevalence of CHD. Dr. Rizky clarified that while these are significant risk factors, they do not guarantee a heart defect, nor does their absence guarantee a healthy heart, as evidenced by the many cases of CHD occurring in infants born to mothers who did not smoke or consume alcohol.
The Indonesian Context: A Critical Public Health Challenge
The scale of the CHD challenge in Indonesia is underscored by sobering statistics. According to data from 2017, Congenital Heart Disease is the second largest contributor to neonatal mortality in Indonesia, accounting for 17 percent of deaths in the first month of life. This figure is surpassed only by complications related to prematurity. The World Health Organization (WHO) estimates that globally, one out of every 100 newborns suffers from some form of CHD. In the Indonesian context, where the birth rate remains high, this translates to tens of thousands of new cases annually.
Of these cases, approximately 25 percent are classified as "critical" CHD. Critical Congenital Heart Disease (CCHD) requires surgical intervention or catheterization within the first year—often within the first days or weeks—of life to ensure survival. Without rapid diagnosis and treatment, these infants face a high risk of death or long-term disability. Dr. Rizky pointed out a harrowing reality: currently, less than 50 percent of CHD cases in Indonesia receive the necessary medical handling. This treatment gap is the result of a multifaceted crisis involving limited access to specialized healthcare, a shortage of pediatric cardiologists and cardiovascular surgeons, and a lack of advanced diagnostic equipment in remote regions.
The Science of Prevention: Vaccination and Nutrition
Given that CHD cannot be "prevented" once a baby is born, the medical community is shifting its focus toward aggressive maternal health interventions. The primary strategy advocated by IDAI is the universal administration of the Rubella vaccine. By ensuring that women of childbearing age are immune to the virus before they conceive, the risk of CRS-related heart defects can be virtually eliminated.
"This is vital when we talk about prevention during pregnancy," Dr. Rizky stated. "Once the baby is born, we are no longer in the phase of prevention, but in the phase of management and intervention."
Beyond vaccination, the role of prenatal supplementation is being championed as a standard of care. High-quality nutrition, supplemented with folic acid, provides the chemical building blocks necessary for healthy fetal development. Public health experts are calling for better education for expectant mothers to avoid self-medicating and to consult with healthcare providers regarding the safety of any pharmaceutical intake during gestation. This proactive approach aims to stabilize the intrauterine environment, giving the fetal heart the best possible chance to form correctly.
Diagnostic Hurdles and the Infrastructure Gap
The delay in diagnosis remains one of the most significant barriers to improving survival rates for children with CHD in Indonesia. In many developed nations, fetal echocardiography allows for the detection of heart defects before birth. However, in Indonesia, such technology and the expertise required to operate it are concentrated in major urban centers like Jakarta, Surabaya, and Medan.
For the majority of the population, the diagnosis must happen after birth. Dr. Rizky highlighted that the initial screening does not necessarily require expensive, high-tech machinery. Simple tools like the stethoscope remain invaluable; the detection of a heart murmur—an unusual sound heard between heartbeats—should immediately trigger a referral for a cardiac evaluation.
However, even more sensitive and cost-effective than a stethoscope for screening purposes is the pulse oximeter. Pulse oximetry screening is a non-invasive test that measures the oxygen saturation level in the blood. By placing sensors on a newborn’s right hand and either foot, healthcare providers can detect discrepancies in oxygen levels that indicate a potential heart defect. This method is fast, relatively inexpensive, and highly sensitive for detecting critical CHD that might not be immediately apparent through physical examination alone.
Early Detection Protocols: The Five-Minute Life-Saving Window
Dr. Rizky and the IDAI are advocating for a standardized screening protocol that can be performed by frontline healthcare workers, including midwives and general practitioners in rural health clinics (Puskesmas). This screening, which takes less than five minutes, could be the difference between life and death for a newborn with a silent heart defect.
The "Critical CHD Screening" should ideally be performed 24 to 48 hours after birth. If the oxygen saturation is low or shows a significant difference between the hand and the foot, the infant is referred for an echocardiogram—an ultrasound of the heart—which is the definitive diagnostic tool for identifying structural abnormalities.
The urgency of this timeline is critical. Many infants with CCHD appear healthy immediately after birth because the ductus arteriosus (a blood vessel present in the fetus) remains open for the first few hours or days, providing a temporary bypass for blood flow. Once this vessel naturally closes, an infant with an undiagnosed heart defect may experience a sudden and catastrophic collapse.
Clinical Manifestations and Parental Vigilance
While medical screening is essential, parental awareness of clinical symptoms is equally important. One of the most common signs of a heart defect in infants is poor weight gain or "failure to thrive." Because the heart must work much harder to pump blood, the infant consumes an excessive amount of calories just to maintain basic functions, often leaving little energy for growth.
Other symptoms include:
- Cyanosis: A bluish tint to the skin, lips, or fingernails, indicating low oxygen levels.
- Tachypnea: Rapid or labored breathing, especially during feeding.
- Diaphoresis: Excessive sweating, particularly on the forehead, during exertion such as nursing.
- Fatigue: The infant may tire easily and fall asleep during feedings before consuming enough milk.
Dr. Rizky emphasized that critical CHD can manifest as early as the first week of life, often within the first 24 to 48 hours. If parents notice any of these signs, they are urged to seek immediate medical attention rather than waiting for scheduled check-ups.
Systemic Solutions and the Role of Digital Education
Addressing the CHD crisis in Indonesia requires a systemic shift that combines government policy, healthcare infrastructure, and public education. The shortage of Human Resources (SDM) is a primary concern. Indonesia currently has a limited number of pediatric cardiologists to serve a population of over 270 million people. Expanding training programs and incentivizing specialists to practice in underserved regions are essential long-term goals.
In the interim, digital education is filling the gap. Dr. Rizky pointed to the YouTube channel "Sehatkan Jantung Anak Indonesia" (Healthy Indonesian Children’s Hearts) as a vital resource for both parents and healthcare workers. This platform provides instructional videos on how to perform screenings and identifies the "red flags" of pediatric heart disease. By democratizing medical knowledge, IDAI hopes to empower local midwives and parents to act as the first line of defense.
The broader implications of failing to address CHD are profound. Beyond the tragic loss of life, the economic burden on families and the state is significant. Children with untreated heart defects often face a lifetime of chronic illness, requiring frequent hospitalizations and limiting their future productivity. Conversely, with early detection and timely intervention, many children with CHD can undergo corrective surgery and lead healthy, full lives.
As Indonesia continues to modernize its healthcare system, the focus on congenital conditions like CHD serves as a litmus test for the nation’s commitment to maternal and child health. The message from the medical community is clear: while the causes of congenital heart disease may be shrouded in biological complexity, the path to reducing its impact is paved with better nutrition, universal vaccination, and a five-minute screening that every newborn deserves. Through the combined efforts of the government, medical professionals, and an informed public, the goal of "Sehatkan Jantung Anak Indonesia" can move from a digital campaign to a national reality.
